FIRST MANHATTAN CO. LLC. - SCOPUS BIOPHARMA INC ownership

SCOPUS BIOPHARMA INC's ticker is SCPS and the CUSIP is 809171101. A total of 18 filers reported holding SCOPUS BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
FIRST MANHATTAN CO. LLC. ownership history of SCOPUS BIOPHARMA INC
ValueSharesWeighting
Q3 2022$3,000
-72.7%
13,100
-49.2%
0.00%
Q2 2022$11,000
-35.3%
25,8000.0%0.00%
Q1 2022$17,000
-59.5%
25,8000.0%0.00%
Q4 2021$42,000
-63.5%
25,800
-7.2%
0.00%
Q3 2021$115,000
+74.2%
27,800
+198.9%
0.00%
Q2 2021$66,000
-24.1%
9,300
-9.7%
0.00%
Q1 2021$87,000
-43.5%
10,300
-1.0%
0.00%
-100.0%
Q4 2020$154,00010,4000.00%
Other shareholders
SCOPUS BIOPHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
M&R CAPITAL MANAGEMENT INC 76,819$33,0000.01%
VANGUARD GROUP INC 54,649$24,0000.00%
UBS Group AG 100$00.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 32,966$14,0000.00%
Compagnie Lombard Odier SCmA 4,360$2,0000.00%
FIRST MANHATTAN CO. LLC. 25,800$11,0000.00%
WELLS FARGO & COMPANY/MN 89$00.00%
NORTHERN TRUST CORP 12,516$5,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 217,078$93,0000.00%
View complete list of SCOPUS BIOPHARMA INC shareholders